Antidepressant drug Fluvoxamine can help reduce Covid hospitalisations by 30%: Study
Antidepressant medicine Fluvoxamine can help reduce hospitalisation rate in high-risk Covid patients by 30 per cent, as per a study published in the Lancet Global Health journal.
This drug is usually used to treat mental health conditions such as obsessive compulsion disorders (OCD), depression, anxiety and such.
Researchers used Fluvoxamine on 739 patients between the time period of January 15 and August 6, this year. These 739 patients hailed from Brazil and were Covid patients. Another group of 733 patients had received placebo. Patients who were given Fluvoxamine were observed for 28 days and the experts kept a track of their health to see if they needed to be hospitalised.
The data proved that people who were administered Fluvoxamine did not have to be admitted to the hospital. The hospitalisation rate had reduced by 30 per cent in case of Fluvoxamine injected patients.
In cases of patients who were taking all their prescribed drugs saw reduction of 65 per cent in hospitalisation rate.